Hovda, Tone
Larsen, Marthe
Bergan, Marie Burns
Gjesvik, Jonas
Akslen, Lars A.
Hofvind, Solveig https://orcid.org/0000-0003-0178-8939
Funding for this research was provided by:
Kreftforeningen (214931)
Article History
Received: 9 December 2024
Revised: 28 January 2025
Accepted: 8 February 2025
First Online: 26 March 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Solveig Hofvind.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper, but M.L. and J.G. have significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board. The data was disclosed with a legal basis in the Cancer Registry Regulations Sections 3–1 and the Personal Health Filing System Act section 19a to 19h.
: Institutional Review Board approval was obtained, i.e., the study was approved by the Regional Committee for Medical and Health Research Ethics (2018/13294).
: Numerous studies have been published using screening examinations from BreastScreen Norway. Results concerning AI using subsamples of the sample in this study have been reported in , , , , and .
: